ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,783.00
-0.71%
S&P ASX All Technology
3,113.80
0.20%
Brent Oil
84.735
0.65%
US Dollar vs AUD
1.50305
-0.13%
Bitcoin
61,360.54
-0.73%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ArQule Inc (ARQL)

  7. ArQule Inc (ARQL) News

ARQL

ArQule (ARQL)

ArQule Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARQL
DateTimeSourceHeadlineSymbolCompany
15/02/202009:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
15/02/202004:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARQLArQule Inc
13/02/202009:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
13/02/202004:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
11/02/202005:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
06/02/202003:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
28/01/202005:55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ARQLArQule Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
07/01/202003:07PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the FirmNASDAQ:ARQLArQule Inc
13/12/201907:49PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.NASDAQ:ARQLArQule Inc
10/12/201919:02Dow Jones NewsMerck, Sanofi Push To Add Cancer Drugs -- WSJNASDAQ:ARQLArQule Inc
10/12/201911:16Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 4th UpdateNASDAQ:ARQLArQule Inc
10/12/201908:37Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 3rd UpdateNASDAQ:ARQLArQule Inc
10/12/201907:12Dow Jones NewsU.S. Stocks Slip as Trade War Weighs on Chinese ExportsNASDAQ:ARQLArQule Inc
10/12/201906:33Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 2nd UpdateNASDAQ:ARQLArQule Inc
10/12/201903:13Dow Jones NewsMerck to Buy ArQule for $2.7 Billion -- UpdateNASDAQ:ARQLArQule Inc
10/12/201900:05Business WireArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...NASDAQ:ARQLArQule Inc
09/12/201923:37PR Newswire (US)(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?NASDAQ:ARQLArQule Inc
09/12/201923:26Dow Jones NewsMerck to Buy ArQule for $2.7 Billion, or $20/ShareNASDAQ:ARQLArQule Inc
09/12/201922:45Business WireMerck to Acquire ArQule, Advancing Leadership in OncologyNASDAQ:ARQLArQule Inc
25/11/201923:00Business WireArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...NASDAQ:ARQLArQule Inc
13/11/201923:00Business WireArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019NASDAQ:ARQLArQule Inc
07/11/201901:05Business WireArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...NASDAQ:ARQLArQule Inc
31/10/201901:57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARQLArQule Inc
30/10/201922:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARQLArQule Inc
30/10/201922:00Business WireArQule Reports Third Quarter 2019 Financial ResultsNASDAQ:ARQLArQule Inc
30/10/201907:01Business WireArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...NASDAQ:ARQLArQule Inc
21/10/201922:00Business WireArQule Announces Preclinical Data Demonstrating Potential of Miransertib (ARQ 092) to Treat PIK3CA-Driven Vascular Malformati...NASDAQ:ARQLArQule Inc
 Showing the most relevant articles for your search:NASDAQ:ARQL

Your Recent History

NASDAQ
GOOGL
Alphabet
ASX
RIO
Rio Tinto
FX
EURAUD
Euro vs AUD
FX
AUDCAD
AUD vs CAD
ASX
WPL
Woodside Petroleum
ASX
MQG
Macquarie
NASDAQ
AAPL
Apple
ASX
QBE
QBE Insurance
ASX
XJO
S&P ASX 200
ASX
TLS
Telstra
ASX
WBC
Westpac Banking
ASX
AMP
AMP
NYSE
MCD
McDonalds
ASX
CBA
Commonwealth Bank Of Aus...
ASX
NCM
Newcrest Mining
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved